Evac Therapy for Rectal Anastomotic Leaks and Perforation

Grande, Giuseppe; Caruso, Angelo; Bertani, Helga; Masciangelo, Graziella; Russo, Salvatore; Pigò, Flavia; Cocca, Silvia; Morando, Fernando Simões; Avallone, Luciana; Conigliaro, Rita

doi:10.1055/s-0040-1704315

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Technical success was defined as successful placement of the Endo-SPONGE in the cavity in 13 of 17 studies 5 6 10 13 14 15 16 17 18 19 20 21 22 . Clinical success was defined as closure of the anastomotic leak, confirmed via endoscopy or contrast enhanced computed tomography imaging 5 6 10 13 14 17 19 21 22 23 24 .…”

Section: Methodsmentioning

confidence: 99%

Endo-sponge in management of anastomotic colorectal leaks: a systematic review and meta-analysis

et al. 2021

View full text Add to dashboard Cite

Background and study aims Following colorectal surgery, anastomotic dehiscence and leak formation has an incidence of 2 % to 7 %. Endo-SPONGE has been applied in the management of anastomatic leaks (ALs) after colorectal surgery. This is the first systematic review and meta analysis to evaluate the efficacy and safety of Endo-SPONGE in the management of colorectal ALs. Patients and methods The primary outcomes assessed were the technical and clinical success of Endo-SPONGE placement in colorectal ALs. The secondary outcomes assessed were the overall adverse events (AEs) and the AE subtypes. Pooled estimates were calculated using random-effects models with 95 % confidence interval (C. I.). The statistical analysis was done using STATA v16.1 software (StataCorp, LLC College Station, Texas, United States). Results The analysis included 17 independent cohort studies with a total of 384 patients. The rate of technical success was 99.86 % (95 % CI: 99.2 %, 100 %; P = 0.00; I2 = 70.69 %) and the calculated pooled rate of clinical success was 84.99 % (95 % CI: 77.4 %, 91.41 %; P = 0.00; I2 = 68.02 %). The calculated pooled rate of adverse events was 7.6 % (95 % CI: 3.99 %, 12.21 %; P = 0.03; I2 = 42.5 %) with recurrent abscess formation and bleeding being the most common AEs. Moderate to substantial heterogeneity was noted in our meta-analysis. Conclusions Endoscopic vacuum therapy appears to be a minimally invasive, safe, and effective treatment modality for patients with a significant colorectal leak without any generalized peritonitis with high clinical and technical success rates and a low rate of adverse events. Further prospective or randomized controlled trials are needed to validate our findings.

show abstract